Several medical procedures—such as mechanical ventilation, autopsies, and bronchoscopies—generate aerosols and come with a high risk of transmitting the novel coronavirus disease (COVID-19) to healthcare workers, according to a recent study.
A head-to-head study comparing five serological assays for SARS-CoV-2 antibodies showed that a commercial immunoassay by Siemens and a novel ELISA* test developed by the University of Oxford could achieve the desired sensitivity and specificity without further optimization — providing reassurance for their use.
A systematic review of randomized controlled trials (RCTs) has confirmed the potential of remdesivir in improving recovery and reducing serious adverse events (AEs), as well as mortality and time to clinical improvement, but not hospital length of stay, in coronavirus disease (COVID-19) patients.
Amid the pandemic of the novel coronavirus disease (COVID-19), healthcare workers in Asia are suffering from high rates of psychological distress, according to a recent study. The rates vary greatly across countries and seem to be independent of the case burden.
Hospitalized COVID-19 patients with prolonged fever showed more pronounced inflammatory response and were more likely to require ICU admission than cases with saddleback fever or with fever lasting ≤7 days, a Singapore study reveals.
Levels of depression, anxiety, and stress among antenatal women increase due to a lack of timely and reliable information on the impact of the novel coronavirus disease (COVID-19) on pregnancy and its outcomes, according to a Singapore study.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.